Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 592

Results For "US"

7124 News Found

Origin Materials and Minafin form strategic partnership for biobased chemicals
News | February 08, 2022

Origin Materials and Minafin form strategic partnership for biobased chemicals

The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries


Biosynthetic Technologies raises $7.5 million
News | February 08, 2022

Biosynthetic Technologies raises $7.5 million

Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.


Thermo Fisher Scientific launches rapid environmental PCR testing solution
Medical Device | February 08, 2022

Thermo Fisher Scientific launches rapid environmental PCR testing solution

Rapid testing produces air sample results in 30 minutes


Everest Medicines' trodelvy approved in Singapore for second-line metastatic triple-negative breast cancer
Drug Approval | February 08, 2022

Everest Medicines' trodelvy approved in Singapore for second-line metastatic triple-negative breast cancer

Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia


GlaxoSmithKline Pharmaceuticals delivers strong financials in Q3FY22
News | February 08, 2022

GlaxoSmithKline Pharmaceuticals delivers strong financials in Q3FY22

EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.


Granules India Q3FY22 PAT at Rs 100.88 cr.
News | February 08, 2022

Granules India Q3FY22 PAT at Rs 100.88 cr.

Granules India has reported consolidated financial results for the period ended December 31, 2021


AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.
News | February 08, 2022

AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.

Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021


Lay Sciences launch ImmynlgY, an oral antibody to neutralize Covid-19
Biotech | February 07, 2022

Lay Sciences launch ImmynlgY, an oral antibody to neutralize Covid-19

ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status


Caplin Point’s Q3 in line; outlook positive amid expansion plans: ICICI Direct
News | February 07, 2022

Caplin Point’s Q3 in line; outlook positive amid expansion plans: ICICI Direct

Key takeaways of recent quarter & conference call highlights


Rahul Guha to join Thyrocare Technologies as MD & CEO
People | February 07, 2022

Rahul Guha to join Thyrocare Technologies as MD & CEO

Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice